Home
Amerigen Pharmaceuticals Limited

Amerigen Pharmaceuticals... Market Share Analysis for May 2026

see relevant content for amerigenpharma.com

Industry: N/A

Domainamerigenpharma.com

Year Founded2007

Employees51 - 200

Annual Revenue$5M - $10M

Amerigen Pharmaceuticals Limited

Amerigen Pharmaceuticals Limited (including company regionals)

amerigenpharma.com

See more website traffic and engagement information

Amerigen Pharmaceuticals Limited Revenue up to May 2026 is 5M - 10M

revenue generated by Amerigen Pharmaceuticals Limited top domains

Amerigen Pharmaceuticals Limited top domains revenue over 3 years

Revenue for Amerigen Pharmaceuticals Limited top domains

amerigenpharma.com5M - 10M

See more with Sales Intelligence

Total visits to Amerigen Pharmaceuticals Limited's top domains

Understand Amerigen Pharmaceuticals Limited market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Amerigen Pharmaceuticals Limited's top domains

Analyze Amerigen Pharmaceuticals Limited engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Amerigen Pharmaceuticals Limited's top domains

See how Amerigen Pharmaceuticals Limited keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Amerigen Pharmaceuticals Limited top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Amerigen Pharmaceuticals Limited

These are the website technologies, by industry, used by Amerigen Pharmaceuticals Limited top domains

Advertising (2)

Google Adsense

Widget (2)

Twemoji

Audio Video Media (1)

Flowplayer

Content Management System (1)

WordPress

More Technologies

3

See all

News & Signals from Amerigen Pharmaceuticals Limited

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAmerigenpharma sold assets to ANI Pharmaceuticals, Inc. in the amount of $52.5M on Jan 9th '20.ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP ) today announced the acquisition of the U.S. portfolio of 23 generic products from Amerigen Pharmaceuticals, Ltd. for $52.5M in cash at close and up to $25M in contingent profit share payments over the next four years.